Dismantling MBRP: Identifying Critical Neuroimmune Mechanisms of Action

拆解 MBRP:识别关键的神经免疫作用机制

基本信息

  • 批准号:
    9036740
  • 负责人:
  • 金额:
    $ 62.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-03-10 至 2021-02-28
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Recent work suggests that the epigenetic regulation of dopamine genes is an important molecular mechanism underlying adaptations in reward circuits. Several studies have also indicated that perturbations in the immune system leading to neuroinflammation is an important mechanism underlying changes in the connectivity of executive control networks. Both of these factors are mechanisms that putatively underlie the etiology and maintenance of alcohol use disorders. A number of studies indicate that mindfulness based interventions may reduce inflammation (i.e., neuroinflammation) and influence epigenetic regulation. Finally, Mindfulness Based Relapse Prevention (MBRP) has recently demonstrated efficacy in the treatment of substance use disorders, although it is not clear how MBRP works. In the first aim of the proposed research, the mindfulness components of MBRP will be dismantled from the relapse prevention components by comparing the effects of an MBRP intervention to a relapse prevention (RP) intervention, thereby isolating the mindfulness effects. In the second aim, the proposed research will examine the mechanisms that may mediate the effects of MBRP by testing the effects of the intervention on inflammatory biomarkers (IL-6, IL-8, and TNFα) as well as the effect of MBRP on epigenetic regulation of key genes (DRD2, SLC6A3, DBH). Further, the proposed work will examine the effects of the intervention on the neural function of the reward system as well as connectivity in executive control networks in the brain. In Aim 3, the research will determine whether the effects of MBRP on immune system function and epigenetic regulation mediate the effects of MBRP on treatment outcomes. To that end, 226 patients will be randomized to 8 weeks of treatment with MBRP or RP. Putative mediators will be assayed at 4 and 8 weeks. Drinking outcomes will be assessed at 4, 8, 20 (12 weeks after the end of treatment), and 32 weeks (24 weeks after the end of treatment). The successful completion of the proposed research is expected to have significant clinical and scientific implications.
 描述(申请人提供):最近的工作表明,多巴胺基因的表观遗传调节是奖赏回路适应的重要分子机制。一些研究还表明,免疫系统的扰动导致神经炎症是导致执行控制网络连通性变化的一个重要机制。这两个因素都是推测酒精使用障碍的病因和维持的机制。许多研究表明,基于正念的干预可能会减少炎症(即神经炎症),并影响表观遗传调节。最后,基于正念的复发预防(MBRP)最近证明了在治疗物质使用障碍方面的有效性,尽管MBRP的工作原理尚不清楚。在拟议研究的第一个目标中,通过比较MBRP干预和复发预防(RP)干预的效果,将MBRP的正念成分从复发预防成分中去除,从而隔离正念效应。在第二个目标中,拟议的研究将通过测试干预对炎性生物标志物(IL-6、IL-8和肿瘤坏死因子α)的影响以及MBRP对关键基因(DRD2、SLC6A3、DBH)的表观遗传调节的影响来研究可能介导MBRP效应的机制。此外,这项拟议的工作将检查干预对奖励系统的神经功能以及大脑执行控制网络连接的影响。在目标3中,研究将确定MBRP对免疫系统功能和表观遗传调节的影响是否介导了MBRP对治疗结果的影响。为此,226名患者将随机接受8周的MBRP或RP治疗。将在4周和8周时对可能的介体进行检测。将在4、8、20(治疗结束后12周)和32周(治疗结束后24周)评估饮酒结果。这项拟议研究的成功完成预计将具有重大的临床和科学意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KENT E. HUTCHISON其他文献

KENT E. HUTCHISON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KENT E. HUTCHISON', 18)}}的其他基金

Rocky Mountain Cannabis Research Center
落基山大麻研究中心
  • 批准号:
    10709326
  • 财政年份:
    2023
  • 资助金额:
    $ 62.28万
  • 项目类别:
Alcohol Use Disorder and Cannabis: Testing Novel Harm Reduction Strategies
酒精使用障碍和大麻:测试新的减害策略
  • 批准号:
    10611953
  • 财政年份:
    2022
  • 资助金额:
    $ 62.28万
  • 项目类别:
Alcohol Use Disorder and Cannabis: Testing Novel Harm Reduction Strategies
酒精使用障碍和大麻:测试新的减害策略
  • 批准号:
    10384999
  • 财政年份:
    2022
  • 资助金额:
    $ 62.28万
  • 项目类别:
Novel Approaches to Opiate Use Reduction
减少阿片类药物使用的新方法
  • 批准号:
    10292835
  • 财政年份:
    2020
  • 资助金额:
    $ 62.28万
  • 项目类别:
Novel Approaches to Opiate Use Reduction
减少阿片类药物使用的新方法
  • 批准号:
    10333401
  • 财政年份:
    2020
  • 资助金额:
    $ 62.28万
  • 项目类别:
Novel Approaches to Opiate Use Reduction
减少阿片类药物使用的新方法
  • 批准号:
    9888123
  • 财政年份:
    2020
  • 资助金额:
    $ 62.28万
  • 项目类别:
Dismantling MBRP: Identifying Critical Neuroimmune Mechanisms of Action
拆解 MBRP:识别关键的神经免疫作用机制
  • 批准号:
    10313471
  • 财政年份:
    2020
  • 资助金额:
    $ 62.28万
  • 项目类别:
Marijuana Harm Reduction: Innovative Strategies for Developing New Knowledge
减少大麻危害:开发新知识的创新策略
  • 批准号:
    10307408
  • 财政年份:
    2020
  • 资助金额:
    $ 62.28万
  • 项目类别:
Novel Approaches to Opiate Use Reduction
减少阿片类药物使用的新方法
  • 批准号:
    10552691
  • 财政年份:
    2020
  • 资助金额:
    $ 62.28万
  • 项目类别:
Marijuana Harm Reduction: Innovative Strategies for Developing New Knowledge
减少大麻危害:开发新知识的创新策略
  • 批准号:
    9126237
  • 财政年份:
    2016
  • 资助金额:
    $ 62.28万
  • 项目类别:

相似海外基金

The investigation of chronic alcohol consumption enhanced aging colon in elder mice and the mechanism of suppressed on aging colon tissues by sesame lignans continuous intake
长期饮酒促进老年小鼠结肠衰老的研究及持续摄入芝麻木脂素抑制结肠组织衰老的机制
  • 批准号:
    23K10904
  • 财政年份:
    2023
  • 资助金额:
    $ 62.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of carcinogenesis and symptoms associated with alcohol consumption
致癌的分子机制和饮酒相关症状
  • 批准号:
    23K05734
  • 财政年份:
    2023
  • 资助金额:
    $ 62.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Internal Sources of Minority Stress and Alcohol Consumption
少数群体压力和饮酒的内部根源
  • 批准号:
    10742318
  • 财政年份:
    2023
  • 资助金额:
    $ 62.28万
  • 项目类别:
Characterizing the Relationship Between Alcohol Consumption and Neuron-Derived Exosomal MicroRNA Cargo in an Adolescent-Young Adult Twin Cohort
青少年双胞胎队列中酒精消耗与神经元衍生的外泌体 MicroRNA 货物之间关系的表征
  • 批准号:
    10452928
  • 财政年份:
    2022
  • 资助金额:
    $ 62.28万
  • 项目类别:
Endocrine regulation of alcohol consumption and fear learning
饮酒和恐惧学习的内分泌调节
  • 批准号:
    10483780
  • 财政年份:
    2022
  • 资助金额:
    $ 62.28万
  • 项目类别:
The impact of friends sharing different modalities of alcohol-related social media content on alcohol consumption: A longitudinal examination of changes in content shared by social networks over time
朋友分享不同形式的酒精相关社交媒体内容对饮酒的影响:对社交网络分享内容随时间变化的纵向研究
  • 批准号:
    10534428
  • 财政年份:
    2022
  • 资助金额:
    $ 62.28万
  • 项目类别:
Cannabis' Impact on Alcohol Consumption: Integrating Laboratory and Ecological Momentary Assessment Methods
大麻对酒精消费的影响:整合实验室和生态瞬时评估方法
  • 批准号:
    10339931
  • 财政年份:
    2022
  • 资助金额:
    $ 62.28万
  • 项目类别:
Chronic alcohol consumption results in elevated Autotaxin levels that suppress anti-tumor immunity
长期饮酒会导致自分泌运动因子水平升高,从而抑制抗肿瘤免疫力
  • 批准号:
    10370159
  • 财政年份:
    2022
  • 资助金额:
    $ 62.28万
  • 项目类别:
Cannabis' Impact on Alcohol Consumption: Integrating Laboratory and Ecological Momentary Assessment Methods
大麻对酒精消费的影响:整合实验室和生态瞬时评估方法
  • 批准号:
    10595096
  • 财政年份:
    2022
  • 资助金额:
    $ 62.28万
  • 项目类别:
Technology-based assessments and intervention to reduce alcohol consumption and improve HIV viral suppression in the Florida Cohort
基于技术的评估和干预,以减少佛罗里达队列的饮酒量并改善艾滋病病毒抑制
  • 批准号:
    10707386
  • 财政年份:
    2022
  • 资助金额:
    $ 62.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了